SUSQUEHANNA INTERNATIONAL GROUP, LLP - EVOKE PHARMA INC ownership

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 14 filers reported holding EVOKE PHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q4 2021$24,000
-36.8%
44,000
+49.7%
0.00%
Q3 2021$38,000
-88.5%
29,400
-87.8%
0.00%
Q2 2021$330,000
-65.1%
241,000
-53.3%
0.00%
Q1 2021$945,000
+37.0%
516,400
+93.0%
0.00%
Q4 2020$690,000
+32.4%
267,514
+141.1%
0.00%
Q3 2020$521,000
+1984.0%
110,968
+275.1%
0.00%
Q3 2019$25,000
-62.1%
29,585
-71.6%
0.00%
Q2 2019$66,000
+106.2%
104,199
+710.9%
0.00%
Q2 2018$32,000
-44.8%
12,850
-50.0%
0.00%
Q4 2017$58,000
+190.0%
25,723
+154.4%
0.00%
Q4 2016$20,00010,1130.00%
Other shareholders
EVOKE PHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Wambolt & Associates, LLC 33,165$29,0000.02%
STATE OF MICHIGAN RETIREMENT SYSTEM 400,000$344,0000.00%
A.R.T. Advisors, LLC 36,954$32,0000.00%
NORTHERN TRUST CORP 33,997$29,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 199,678$171,0000.00%
CITIGROUP INC 500$00.00%
MORGAN STANLEY 1,450$1,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 36,700$32,0000.00%
BlackRock Inc. 54,940$47,0000.00%
View complete list of EVOKE PHARMA INC shareholders